NVP-EGT710
NVP-EGT710 is an orally active non-peptidomimetic covalent SARS-CoV-2 Mpro inhibitor. NVP-EGT710 can be used for coronavirus infection research[1].
Product Specifications
CAS Number
[2893895-11-7]
Product Name Alternative
EGT710
UNSPSC
12352005
Target
SARS-CoV; Virus Protease
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
N#C[C@H]1CN(C(N1C2=CN=CC3=C2C=CC=C3)=O)C4=CC=C(N=C4)C(F)(F)F
Molecular Formula
C19H12F3N5O
Molecular Weight
383.33
References & Citations
[1]Matt Hesse. NVP-EGT710: Novartis’ Oral Covalent SARS-CoV-2 Mpro Inhibitor from Screen to Candidate in 18 Months. Oct. 29, 2025.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
C2085-57U-ML650 100 µL
CSNK1G3, CT (Casein Kinase I Isoform gamma-3, CKI-gamma 3) (MaxLight 650) discontinued
Ask
View Details